. Author manuscript; available in PMC: 2014 Feb 1.

Published in final edited form as: Am J Kidney Dis. 2012 Nov 11;61(2):228–237. doi: 10.1053/j.ajkd.2012.09.009

Table 2.

3MS scores in the Daily trial and Nocturnal Trial

Trial	Treatment arm	Observed Data			Adjusted Means and Treatment Effect (± SE or with 95% CI)
		Mo 0	Mo 4	Mo 12	Mo 4		Mo 12
		Mo 0	Mo 4	Mo 12	Mo 4 vs Mo 0	6x/wk vs. 3x/wk	Mo 12 vs Mo 0	6x/wk vs. 3x/wk
Daily Trial^*	3x/wk	87 ± 10	88 ± 10	89 ± 9	+1.1 ± 0.7	−0.0 (−1.8 to 1.5)	+1.9 ± 0.8	+0.2 (−1.8 to 2.2)
Daily Trial^*	6x/wk	87 ± 9	88 ±10	89 ± 10	+1.0 ± 0.6	−0.0 (−1.8 to 1.5)	+2.1 ± 0.7	+0.2 (−1.8 to 2.2)
Nocturnal Trial^**	3x/wk	90 ± 6	94 ± 6	95 ± 4	+3.5 ± 0.8	−2.1 (−4.3 to 0.0)	+4.4 ± 1.1	−2.3 (−5.4 to0.8)
Nocturnal Trial^**	6x/wk	90 ± 8	92 ± 10	93 ± 12	+1.3 ± 0.8	−2.1 (−4.3 to 0.0)	+2.1 ± 1.1	−2.3 (−5.4 to0.8)

Note: Values for observed data are given as mean ± SD; other values given as adjusted mean ± SE or treatment effect (95% CI).

Values adjusted for baseline score and clinical center

^**

Values adjusted for baseline score

Abbreviations: 3MS, Modified Mini-Mental State Examination; SD - standard deviation, SE - standard error, CI - confidence interval

The maximum (best) score on the 3MS is 100.